Multispectral optoacoustic tomography enables assessment of disease activity in paediatric inflammatory bowel disease

Multispectral optoacoustic tomography (MSOT) allows non-invasive molecular disease activity assessment in adults with inflammatory bowel disease (IBD). In this prospective pilot-study, we investigated, whether increased levels of MSOT haemoglobin parameters corresponded to inflammatory activity in p...

Full description

Saved in:
Bibliographic Details
Published in:Photoacoustics (Munich) Vol. 35; p. 100578
Main Authors: Regensburger, Adrian P, Eckstein, Markus, Wetzl, Matthias, Raming, Roman, Paulus, Lars-Philip, Buehler, Adrian, Nedoschill, Emmanuel, Danko, Vera, Jüngert, Jörg, Wagner, Alexandra L, Schnell, Alexander, Rückel, Aline, Rother, Ulrich, Rompel, Oliver, Uder, Michael, Hartmann, Arndt, Neurath, Markus F, Woelfle, Joachim, Waldner, Maximilian J, Hoerning, André, Knieling, Ferdinand
Format: Journal Article
Language:English
Published: Germany Elsevier 01-02-2024
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Multispectral optoacoustic tomography (MSOT) allows non-invasive molecular disease activity assessment in adults with inflammatory bowel disease (IBD). In this prospective pilot-study, we investigated, whether increased levels of MSOT haemoglobin parameters corresponded to inflammatory activity in paediatric IBD patients, too. 23 children with suspected IBD underwent MSOT of the terminal ileum and sigmoid colon with standard validation (e.g. endoscopy). In Crohn`s disease (CD) and ulcerative colitis (UC) patients with endoscopically confirmed disease activity, MSOT total haemoglobin (HbT) signals were increased in the terminal ileum of CD (72.1 ± 13.0 a.u. vs. 32.9 ± 15.4 a.u., p = 0.0049) and in the sigmoid colon of UC patients (62.9 ± 13.8 a.u. vs. 35.1 ± 16.3 a.u., p = 0.0311) as compared to controls, respectively. Furthermore, MSOT haemoglobin parameters correlated well with standard disease activity assessment (e.g. SES-CD and MSOT HbT (r =0.69, p = 0.0075). Summarizing, MSOT is a novel technology for non-invasive molecular disease activity assessment in paediatric patients with inflammatory bowel disease.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
Authors contributed equally to the work
ISSN:2213-5979
2213-5979
DOI:10.1016/j.pacs.2023.100578